Discover how scientists engineered goldenberry plants to grow 35% shorter than usual, making them suitable for large-scale ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Investors seeking stocks with explosive growth potential should consider the biotech industry. Drugmakers can experience ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Technion’s highest honor recognizes Mirkin for pioneering discoveries in nanoscience, including the Spherical Nucleic Acid (SNA) technology that forms the foundation of Flashpoint’s structural ...
The global pest control industry is steering towards a whopping $32.8 billion valuation by 2028, growing at a compound annual ...
Penn Medicine shows how sustained research investment drives innovation, economic growth, and global health breakthroughs.
ZME Science on MSN
Scientists Engineered a Supercharged Quorn Fungus That Makes Nearly Double the Protein
Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team and Dr. Claire Harrison will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback